As another cannabis earnings season comes to a close, the financial results from some of the smaller U.S. multi-state operators (MSOs) have fallen under the radar, despite posting awe-inspiring numbers.... read more →
While there have been glimmers of an upturn recently in the cannabis industry, the drama of the business of selling a federally illegal cash crop continues. And there is little... read more →
Hollister Biosciences Also Provided a Corporate Update on the Company's Business Operations During the Coronavirus Pandemic Thanks to Cannabis Being Deemed Essential in the States Hollister Operates In, the Company... read more →
The AlphaMind Acquisition is a Milestone Moment for the Rapidly Ascending Cannabis Company With the Transformational Deal Now Complete, Hollister Has Officially Diversified into the Flourishing World of Psychedelics Hollister... read more →
Welcome to the Cannabis Countdown. In this week’s rendition, we’ll recap and countdown the top 10 Marijuana and Psychedelic stock news stories for the week of April 20th – 26th, 2020.... read more →
Hollister Biosciences, One of the Hottest Names in Cannabis, is Moving Forward with Another Blockbuster Deal Following its Recent Acquisition of Venom Extracts Hollister Announced That it Reached a Definitive... read more →
Hollister Biosciences is on a Roll, and the Investing Community is Finally Giving the Company the Attention it Rightfully Deserves Since Bottoming at the Start of April, HOLL Stock Has... read more →
Hollister Biosciences Signs LOI to Acquire Legal Medicinal Mushroom and Psilocybin Firm Alphamind Brands Alphamind is Developing Mushroom Products and Conducting R&D for Psilocybin Pharmaceutical Applications Hollister Biosciences (CSE: HOLL)... read more →
